{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:00Z","timestamp":1772119740789,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10646-5","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T01:43:39Z","timestamp":1749865419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and clinical significance of autoantibodies to sulphite oxidase and glycogen phosphorylase in Chinese primary biliary cholangitis patients"],"prefix":"10.1007","volume":"52","author":[{"given":"Rohil","family":"Jawed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"issue":"12","key":"10646_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353(12):1261\u20131273","journal-title":"N Engl J Med"},{"issue":"2","key":"10646_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.path.2018.02.010","volume":"11","author":"RS Gonzalez","year":"2018","unstructured":"Gonzalez RS, Washington K (2018) Primary biliary cholangitis and autoimmune hepatitis. Surg Pathol Clin 11(2):329\u2013349","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"10646_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12328-017-0799-z","volume":"11","author":"S Joshita","year":"2018","unstructured":"Joshita S, Umemura T, Tanaka E, Ota M (2018) Genetics and epigenetics in the pathogenesis of primary biliary cholangitis. Clin J Gastroenterol 11(1):11\u201318","journal-title":"Clin J Gastroenterol"},{"issue":"12","key":"10646_CR4","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3748\/wjg.v29.i12.1795","volume":"29","author":"EI Rigopoulou","year":"2023","unstructured":"Rigopoulou EI, Bogdanos DP (2023) Role of autoantibodies in the clinical management of primary biliary cholangitis. World J Gastroenterol 29(12):1795\u20131810","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10646_CR5","first-page":"445","volume":"84","author":"R Klein","year":"1991","unstructured":"Klein R, Berg PA (1991) Anti-M4 antibodies in primary biliary cirrhosis React with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space. Clin Exp Immunol 84(3):445\u2013448","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10646_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2249.1990.tb05292.x","volume":"81","author":"R Klein","year":"1990","unstructured":"Klein R, Berg PA (1990) Anti-M9 antibodies in Sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase. Clin Exp Immunol 81(1):65\u201371","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10646_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0168-8278(95)80073-5","volume":"23","author":"L Dubel","year":"1995","unstructured":"Dubel L, Boulay-Stref N, Poupon R, Farges O, Homberg JC, Johanet C (1995) The hopital saint Antoine and hopital Paul brousse experience of anti-M4 and anti-M9 antibodies as markers of severity of primary biliary cirrhosis. J Hepatol 23(5):627\u2013628","journal-title":"J Hepatol"},{"issue":"2","key":"10646_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0168-8278(05)80253-3","volume":"18","author":"JM Palmer","year":"1993","unstructured":"Palmer JM, Yeaman SJ, Bassendine MF, James OF (1993) M4 and M9 autoantigens in primary biliary cirrhosis\u2013a negative study. J Hepatol 18(2):251\u2013254","journal-title":"J Hepatol"},{"issue":"3","key":"10646_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0168-8278(88)80046-1","volume":"6","author":"R Klein","year":"1988","unstructured":"Klein R, Kloppel G, Fischer R, Fintelmann V, Muting D, Berg PA (1988) The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosis. J Hepatol 6(3):299\u2013306","journal-title":"J Hepatol"},{"issue":"36","key":"10646_CR10","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.3748\/wjg.v11.i36.5706","volume":"11","author":"R Flisiak","year":"2005","unstructured":"Flisiak R, Pelszynska M, Prokopowicz D, Rogalska M, Grygoruk U (2005) High concentration of antimitochondrial antibodies predicts progressive primary biliary cirrhosis. World J Gastroenterol 11(36):5706\u20135709","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10646_CR11","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/hep.1840160505","volume":"16","author":"PA Davis","year":"1992","unstructured":"Davis PA, Leung P, Manns M, Kaplan M, Munoz SJ, Gorin FA et al (1992) M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena? Hepatology 16(5):1128\u20131136","journal-title":"Hepatology"},{"issue":"9\u201310","key":"10646_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00251-020-01192-4","volume":"72","author":"R Jawed","year":"2020","unstructured":"Jawed R, Zhang M, Wang C, Yang SH, Jiang P, Wu Q et al (2020) Replication study and meta-analysis indicate a suggestive association of RUNX3 locus with primary biliary cholangitis. Immunogenetics 72(9\u201310):467\u2013474","journal-title":"Immunogenetics"},{"issue":"1","key":"10646_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ et al (2009) Primary biliary cirrhosis. Hepatology 50(1):291\u2013308","journal-title":"Hepatology"},{"issue":"3","key":"10646_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Pares","year":"2006","unstructured":"Pares A, Caballeria L, Rodes J (2006) Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 130(3):715\u2013720","journal-title":"Gastroenterology"},{"issue":"3","key":"10646_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C et al (2008) Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 48(3):871\u2013877","journal-title":"Hepatology"},{"issue":"12","key":"10646_CR16","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/82449","volume":"18","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Muyrers JP, Testa G, Stewart AF (2000) DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol 18(12):1314\u20131317","journal-title":"Nat Biotechnol"},{"key":"10646_CR17","doi-asserted-by":"publisher","first-page":"14828","DOI":"10.1038\/ncomms14828","volume":"8","author":"F Qiu","year":"2017","unstructured":"Qiu F, Tang R, Zuo X, Shi X, Wei Y, Zheng X et al (2017) A genome-wide association study identifies six novel risk loci for primary biliary cholangitis. Nat Commun 8:14828","journal-title":"Nat Commun"},{"issue":"5","key":"10646_CR18","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.510230512","volume":"23","author":"O Bandin","year":"1996","unstructured":"Bandin O, Courvalin JC, Poupon R, Dubel L, Homberg JC, Johanet C (1996) Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 23(5):1020\u20131024","journal-title":"Hepatology"},{"issue":"5","key":"10646_CR19","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1073\/pnas.92.5.1639","volume":"92","author":"K Xie","year":"1995","unstructured":"Xie K, Snyder M (1995) Two short autoepitopes on the nuclear Dot antigen are similar to epitopes encoded by the Epstein-Barr virus. Proc Natl Acad Sci U S A 92(5):1639\u20131643","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10646_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/apt.13927","volume":"45","author":"F Yang","year":"2017","unstructured":"Yang F, Yang Y, Wang Q, Wang Z, Miao Q, Xiao X et al (2017) The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210. Aliment Pharmacol Ther 45(5):733\u2013743","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10646_CR21","first-page":"68","volume":"74","author":"R Klein","year":"1988","unstructured":"Klein R, Berg PA (1988) Characterization of a new mitochondrial antigen-antibody system (M9\/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis. Clin Exp Immunol 74(1):68\u201374","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10646_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-2249.2007.03482.x","volume":"150","author":"B Preuss","year":"2007","unstructured":"Preuss B, Berg C, Altenberend F, Gregor M, Stevanovic S, Klein R (2007) Demonstration of autoantibodies to Recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance. Clin Exp Immunol 150(2):312\u2013321","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10646_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M et al (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45(1):118\u2013127","journal-title":"Hepatology"},{"issue":"29","key":"10646_CR24","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.3748\/wjg.v16.i29.3616","volume":"16","author":"C-J Hu","year":"2010","unstructured":"Hu C-J, Zhang F-C, Li Y-Z, Zhang X (2010) Primary biliary cirrhosis: what do autoantibodies tell Us?? World J Gastroenterology: WJG 16(29):3616","journal-title":"World J Gastroenterology: WJG"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10646-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:28:33Z","timestamp":1766852913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10646-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10646"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10646-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6373642\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of southeast university hospital and in accordance with the guidelines of the Declaration of Helsinki (2008). Written informed consent was obtained from each patient prior to screening on the approved informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. All authors approved the final manuscript and its submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The funding organizations played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of interest"}}],"article-number":"593"}}